What researchers published on Follicular lymphoma
367 papers, newest first.
Showing 20 of 367
ReviewBeyond the plateau: defining cure and charting the next decade in follicular lymphoma: redefining cure in follicular lymphoma.Medical oncology (Northwood, London, England)
Review[Treatment strategies for lymphoma in older adults].[Rinsho ketsueki] The Japanese journal of clinical hematology
ReviewLow tumor burden follicular lymphoma: The state of the art.HemaSphere
Not labelled yetPrognostic value of cell differentiation-related genes in follicular lymphoma based on integrated single-cell and bulk RNA sequencing.Neoplasma
Case reportPersistent Campylobacter jejuni enterocolitis after CAR T-cell therapy in a patient with hypogammaglobulinemic follicular lymphoma.ASM case reports
Case reportLower Back Pain As the Initial Manifestation of Primary Follicular B-cell Non-Hodgkin Lymphoma of the Bone Marrow: A Case Report.Cureus
Not labelled yetFollicular Lymphoma: 2027 Annual Update.American journal of hematology
Not labelled yetZanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma: Final Analysis of the Phase 2 ROSEWOOD Study.Targeted oncology
Not labelled yetBaseline maximum standardised uptake value does not predict outcomes in high-tumour-burden follicular lymphoma treated with first-line immunochemotherapy.British journal of haematology
Case report[Composite follicular lymphoma and mantle cell lymphoma: report of a case].Zhonghua bing li xue za zhi = Chinese journal of pathology
Not labelled yetAssessment of BCL-2 expression in bone marrow by flow cytometry to aid in the diagnosis and differential diagnosis in patients with follicular lymphoma.Cytometry. Part B, Clinical cytometry
Not labelled yetComparative survival and time toxicity outcomes of CAR-T versus bispecific antibody therapies in relapsed/refractory FL.Blood advances
Review[Treatment strategies and future perspectives in follicular lymphoma].[Rinsho ketsueki] The Japanese journal of clinical hematology
Not labelled yetObinutuzumab and Chemotherapy for Front-Line Treatment of Follicular Lymphoma Grade 3B and Composite Follicular Lymphoma: A Study of the Croatian Cooperative Group for Hematologic Diseases (KroHem).Pharmaceuticals (Basel, Switzerland)
Not labelled yetNavigating T-Cell-Directed Therapies in Transformed Follicular Lymphoma.Cancers
Not labelled yetClinical Characteristics, Progression of Disease Within 24 Months (POD24), and Real-World Outcomes of Follicular Lymphoma in Saudi Arabia: A Two-Centre Retrospective Analysis.Cancers
Not labelled yetAdjusted Indirect Comparison Between Epcoritamab-R2 and Tafasitamab-R2 in Relapse/Refractory Follicular Lymphoma.Hematological oncology
Not labelled yetCAR-HEMATOTOX score to predict risk of poor outcomes with odronextamab in heavily pretreated B-cell non-Hodgkin lymphoma.British journal of haematology
Not labelled yetNewly diagnosed and relapsed follicular lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.HemaSphere
Not labelled yetCapsule retention revealing systemic follicular lymphoma with small-bowel involvement.Gastroenterologia y hepatologia